Changbai Shan Pharmaceutical

Changbaishan Pharmaceutical is a modernized, high-tech pharmaceutical company based in Jilin, China, specializing in the research, development, manufacturing, and commercialization of Traditional Chinese Medicine (TCM) and natural health products. Founded in 2001, the company has established a robust portfolio of proprietary and patented products, particularly focusing on oncology, cardiovascular and cerebrovascular diseases, and pediatric health. Its flagship products include Kangai Injection, an adjuvant therapy widely used in China for various cancers, and Tribulus Terrestris Saponin Capsule for cerebral infarction. Changbaishan Pharmaceutical operates state-of-the-art manufacturing facilities that comply with national Good Manufacturing Practice (GMP) standards, ensuring high-quality production of tablets, capsules, and small-volume injections.